News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
148,517 Results
Type
Article (10216)
Company Profile (39)
Press Release (138259)
Multimedia
Podcasts (15)
Webinars (4)
Section
Business (44611)
Career Advice (158)
Deals (5826)
Drug Delivery (44)
Drug Development (24612)
Employer Resources (7)
FDA (2443)
Job Trends (2382)
News (70753)
Policy (4514)
Tag
2027 BioCapital Standard (2)
2027 BioMidwest Digital (1)
2027 BioMidwest Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (824)
Academic (1)
Accelerated approval (20)
ADA (23)
Adcomms (5)
Allergies (31)
Alliances (13315)
ALS (89)
Alzheimer's disease (691)
Antibody-drug conjugate (ADC) (296)
Approvals (2599)
Artificial intelligence (348)
ASCO (120)
Autoimmune disease (149)
Automation (21)
Bankruptcy (39)
Belgium (8)
Best Places to Work (2060)
BIO (26)
Biologics (19)
BIOSECURE Act (4)
Biosimilars (46)
BioSpace Insights (30)
Biotechnology (29)
Bispecific (27)
Bladder cancer (53)
Brain cancer (37)
Breast cancer (312)
Cancer (2785)
Cardiovascular disease (153)
Career advice (149)
Career pathing (6)
CAR-T (71)
CDC (2)
CDMO (50)
Cell therapy (179)
Cervical cancer (7)
Clinical research (21514)
Collaboration (977)
Commercialization (13)
Company closure (2)
Compensation (395)
Complete response letters (21)
COVID-19 (729)
CRISPR (35)
CRO (1)
C-suite (411)
Cystic fibrosis (67)
Data (3581)
Denatured (2)
Depression (39)
Dermatology (39)
Diabetes (218)
Diagnostics (3210)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (240)
Drug pricing (41)
Drug shortages (2)
Duchenne muscular dystrophy (99)
Earnings (14208)
Editorial (10)
Employer branding (2)
Employer resources (7)
ESMO (150)
Events (24095)
Executive appointments (330)
Eye disease (3)
FDA (3471)
Fibrodysplasia Ossificans Progressiva (5)
Fragile X (1)
Friedreich's ataxia (9)
Frontotemporal dementia (19)
Funding (601)
Gene editing (62)
Generative AI (45)
Gene therapy (182)
GLP-1 (472)
Government (656)
Grass and pollen (1)
Guidances (86)
Healthcare (3026)
Hematology (57)
HIV (11)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (28)
Immunology and inflammation (150)
Immuno-oncology (46)
Indications (82)
Infectious disease (850)
Inflammatory bowel disease (85)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (16)
IPO (2835)
IRA (20)
Job creations (397)
Job search strategy (132)
JPM (16)
Kidney cancer (16)
Kidney disease (47)
Labor market (7)
Layoffs (73)
Leadership (3)
Legal (504)
Licensing (31)
Liver cancer (35)
Longevity (19)
Lung cancer (432)
Lung diease (12)
Lymphoma (171)
Machine learning (31)
Management (1)
Manufacturing (324)
Marketing (4)
MASH (87)
Medical device (721)
Medtech (736)
Mergers & acquisitions (3295)
Metabolic disorders (671)
mRNA (77)
Multiple sclerosis (93)
Multispecific (5)
NASH (9)
Netherlands (11)
Neurodegenerative disease (219)
Neuropsychiatric disorders (45)
Neuroscience (1384)
NextGen: Class of 2026 (834)
Non-profit (535)
Now hiring (20)
Obesity (347)
Opinion (78)
Ovarian cancer (115)
Pain (83)
Pancreatic cancer (129)
Parkinson's disease (162)
Partnered (14)
Patents (192)
Patient recruitment (290)
Patient selection (33)
Peanut (6)
People (13359)
Peptides (8)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (8215)
Phase 2 (10164)
Phase 3 (5731)
Pipeline (4060)
Policy (52)
Postmarket research (267)
Preclinical (4230)
Press Release (22)
Prostate cancer (146)
Psychedelics (21)
Radioligand (2)
Radiopharmaceuticals (207)
Rare diseases (382)
Real estate (812)
Recruiting (4)
Regenerative medicine (3)
Regulatory (4843)
Reports (16)
Research institute (888)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (16)
RSV (20)
Schizophrenia (50)
Series A (121)
Series B (79)
Sickle cell disease (43)
Special edition (5)
Spinal muscular atrophy (64)
Sponsored (19)
Startups (1049)
Stem cells (2)
Stomach cancer (4)
Substance use disorders (3)
Supply chain (16)
Switzerland (6)
Tariffs (15)
The Weekly (13)
Vaccines (152)
Venture capital (48)
Weight loss (200)
Wet AMD (2)
Women's health (23)
Worklife (1)
Date
Today (48)
Last 7 days (233)
Last 30 days (824)
Last 365 days (8326)
2026 (6888)
2025 (8109)
2024 (9220)
2023 (10618)
2022 (12895)
2021 (13134)
2020 (11238)
2019 (7731)
2018 (5838)
2017 (7136)
2016 (6628)
2015 (8038)
2014 (5473)
2013 (4300)
2012 (4393)
2011 (4780)
2010 (4129)
Location
Africa (106)
Alabama (65)
Alaska (1)
Arizona (33)
Arkansas (2)
Asia (10106)
Australia (1624)
California (4687)
Canada (992)
China (788)
Colorado (123)
Connecticut (215)
Delaware (133)
Europe (23945)
Florida (556)
Georgia (64)
Idaho (7)
Illinois (263)
India (44)
Indiana (188)
Iowa (4)
Japan (212)
Kansas (13)
Kentucky (8)
Louisiana (9)
Maine (4)
Maryland (365)
Massachusetts (3573)
Michigan (69)
Minnesota (87)
Mississippi (2)
Missouri (26)
Montana (4)
Nebraska (2)
Nevada (14)
New Hampshire (7)
New Jersey (915)
New Mexico (13)
New York (1241)
North Carolina (470)
North Dakota (7)
Northern California (2616)
Ohio (74)
Oklahoma (11)
Oregon (19)
Pennsylvania (499)
Puerto Rico (4)
Rhode Island (14)
South America (138)
South Carolina (6)
Southern California (1763)
Tennessee (53)
Texas (675)
United States (14615)
Utah (217)
Virginia (55)
Washington D.C. (7)
Washington State (323)
West Virginia (1)
Wisconsin (82)
Wyoming (2)
148,517 Results for "dice molecules".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HotSpot Therapeutics to Present Preclinical Data on Small Molecule IRF5 Inhibitor HST-2011 at ACR Convergence 2026
October 28, 2026
·
2 min read
Press Releases
Catalent Launches Accelerated Gene-to-Drug Substance Program for Complex Molecules in the U.S.
October 5, 2026
·
2 min read
Funding
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
While peptides are currently the dominant approach to GLP-1 agonism, Ambrosia Biosciences is pursuing a small-molecule approach.
April 1, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules
October 13, 2026
·
2 min read
Press Releases
Hankang Pharmaceutical Reaches Key Milestone in AI-Driven Small Molecule Discovery Program for Oncology and Autoimmune Diseases
Program supported by a Tianjin Municipal Major Special Project marks Hankang’s move from development partner to originator of Class 1 innovative drugs.
October 12, 2026
·
1 min read
Press Releases
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
September 30, 2026
·
2 min read
Press Releases
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
October 26, 2026
·
11 min read
Press Releases
insitro Designed Machine Learning Models for Small Molecule in vivo Pharmacokinetic Behavior Prediction Now Available in Lilly TuneLab
October 6, 2026
·
4 min read
Press Releases
Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity
October 26, 2026
·
5 min read
Press Releases
OMass Therapeutics Announces $310 Million Series C Financing to Advance Portfolio of Small Molecule Therapeutics in Endocrinology and Immunology
October 15, 2026
·
4 min read
1 of 14,852
Next
